KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $20.5 billion.

  • Biogen's Non-Current Assets fell 61.72% to $20.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $81.5 billion, marking a year-over-year decrease of 9.35%. This contributed to the annual value of $20.5 billion for FY2025, which is 61.72% down from last year.
  • Biogen's Non-Current Assets amounted to $20.5 billion in Q4 2025, which was down 61.72% from $20.3 billion recorded in Q3 2025.
  • Biogen's 5-year Non-Current Assets high stood at $21.5 billion for Q3 2024, and its period low was $14.7 billion during Q2 2023.
  • Its 5-year average for Non-Current Assets is $18.0 billion, with a median of $18.5 billion in 2021.
  • As far as peak fluctuations go, Biogen's Non-Current Assets tumbled by 1125.84% in 2022, and later soared by 3537.65% in 2023.
  • Quarter analysis of 5 years shows Biogen's Non-Current Assets stood at $16.0 billion in 2021, then decreased by 7.85% to $14.8 billion in 2022, then surged by 35.38% to $20.0 billion in 2023, then grew by 3.04% to $20.6 billion in 2024, then dropped by 0.62% to $20.5 billion in 2025.
  • Its Non-Current Assets stands at $20.5 billion for Q4 2025, versus $20.3 billion for Q3 2025 and $20.4 billion for Q2 2025.